Shares of Siemens Healthineers AG (OTCMKTS:SMMNY – Get Free Report) shot up 0.6% during trading on Monday. The company traded as high as $23.66 and last traded at $23.58. 56,932 shares traded hands during mid-day trading, a decline of 57% from the average daily volume of 131,594 shares. The stock had previously closed at $23.44.
Analyst Upgrades and Downgrades
Several analysts have weighed in on the stock. Zacks Research downgraded shares of Siemens Healthineers from a “hold” rating to a “strong sell” rating in a research report on Thursday, October 1st. Deutsche Bank Aktiengesellschaft reaffirmed a “hold” rating on shares of Siemens Healthineers in a report on Tuesday, August 18th. Citigroup reiterated a “buy” rating on shares of Siemens Healthineers in a research note on Tuesday, October 13th. Finally, Royal Bank Of Canada reissued an “outperform” rating on shares of Siemens Healthineers in a report on Friday, October 16th. One equities research analyst has rated the stock with a Strong Buy rating, two have given a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, Siemens Healthineers presently has an average rating of “Moderate Buy”.
Get Our Latest Stock Analysis on SMMNY
Siemens Healthineers Stock Up 0.6%
The business has a fifty day moving average price of $22.35 and a two-hundred day moving average price of $22.09.
About Siemens Healthineers
Siemens Healthineers AG is a global medical technology company headquartered in Erlangen, Germany. The company develops, manufactures and provides products, services and digital solutions that support the prevention, diagnosis and treatment of disease. Siemens Healthineers operates as a separately managed company within the broader Siemens group and has served healthcare providers in markets around the world.
Its portfolio includes medical imaging systems such as computed tomography, magnetic resonance imaging, X-ray and molecular imaging equipment, as well as ultrasound systems.
Further Reading
- Five stocks we like better than Siemens Healthineers
- Comfort Systems Earnings: AI Slowdown or More Growth Ahead?
- Bristol Myers Squibb’s Cancer Breakthrough Could Have Implications Beyond Its Own Stock
- 5 Beaten-Down Growth Stocks Trading Like Value Plays as Cash Chases Mega-Caps
- Anthropic’s IPO Filing Reveals a Massive Opportunity for AI Infrastructure Giants
Receive News & Ratings for Siemens Healthineers Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Siemens Healthineers and related companies with MarketBeat.com's FREE daily email newsletter.
